Drug-induced life-threatening arrhythmias and sudden cardiac death: A clinical perspective of long QT, short QT and Brugada syndromes

Priori, 2015, Europace, 17, 1601 Silva, 2014, Sudden cardiac death in young adult, Cardiovasc Toxicol, 14, 379, 10.1007/s12012-014-9255-1 John, 2012, Ventricular arrhythmias and sudden cardiac death, Lancet, 380, 1520, 10.1016/S0140-6736(12)61413-5 Goyal, 2016, Pathophysiology and prevention of sudden cardiac death, Can J Physiol Pharmacol, 94, 237, 10.1139/cjpp-2015-0366 Bardai, 2013, Sudden cardiac arrest associated with use of a non-cardiac drug that reduces cardiac excitability: evidence from bench, bedside, and community, Eur Heart J, 34, 1506, 10.1093/eurheartj/eht054 Teodorescu, 2013, Antipsychotic drugs are associated with pulseless electrical activity: the Oregon Sudden Unexpected Death Study, Heart Rhythm, 10, 526, 10.1016/j.hrthm.2012.12.002 Prystowsky, 2012, Ventricular arrhythmias in the absence of structural heart disease, J Am Coll Cardiol, 59, 1733, 10.1016/j.jacc.2012.01.036 Chohan, 2015, Antipsychotic medication and QT prolongation, Pak J Med Sci, 31, 1269 Nielsen, 2011, Assessing QT interval prolongation and its associated risks with antipsychotics, CNS Drugs, 25, 473, 10.2165/11587800-000000000-00000 Konstantopoulou, 2013, Mechanisms of drug-induced proarrhythmia in clinical practice, World J Cardiol, 5, 175, 10.4330/wjc.v5.i6.175 Drew, 2010, Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation, J Am Coll Cardiol, 55, 934, 10.1016/j.jacc.2010.01.001 Roden, 2004, Drug-induced prolongation of the QT interval, N Engl J Med, 350, 1013, 10.1056/NEJMra032426 Nakajima, 2015, Unveiling specific triggers and precipitating factors for fatal cardiac events in inherited arrhythmia syndromes, Circ J, 79, 1185, 10.1253/circj.CJ-15-0322 Niemeijer, 2015, Pharmacogenetics of drug-induced QT interval prolongation: an update, Drug Saf, 38, 855, 10.1007/s40264-015-0316-6 van Hoeijen, 2014, Cardiac sodium channels and inherited electrophysiological disorders: an update on the pharmacotherapy, Expert Opin Pharmacother, 15, 1875, 10.1517/14656566.2014.936380 Ackerman, 2011, HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA), Europace, 13, 1077, 10.1093/europace/eur245 Schwartz, 2011, QTc behavior during exercise and genetic testing for the long-QT syndrome, Circulation, 124, 2181, 10.1161/CIRCULATIONAHA.111.062182 Gussak, 2000, Idiopathic short QT interval: a new clinical syndrome?, Cardiology, 94, 99, 10.1159/000047299 Ramakrishna, 2015, Sudden cardiac death and disorders of the QT interval: anesthetic implications and focus on perioperative management, J Cardiothorac Vasc Anesth, 29, 1723, 10.1053/j.jvca.2015.07.026 Brugada, 1992, Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report, J Am Coll Cardiol, 20, 1391, 10.1016/0735-1097(92)90253-J Antzelevitch, 2016, Brugada syndrome: clinical, genetic, molecular, cellular, and ionic aspects, Curr Probl Cardiol, 41, 7, 10.1016/j.cpcardiol.2015.06.002 Juang, 2016, Genetics of Brugada syndrome, J Arrhythm, 32, 418, 10.1016/j.joa.2016.07.012 Antzelevitch, 2016, Europace Priori, 2013, HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013, Heart Rhythm, 10, 1932, 10.1016/j.hrthm.2013.05.014 Woosley R, Heise CW, Romero KA. QTdrugs List. AZCERT, Inc., 1822 Innovation Park Dr., Oro Valley, AZ 85755. www.CredibleMeds.org [accessed 12.01.17]. Postema, 2013, Safe drug use in long QT syndrome and Brugada syndrome: comparison of website statistics, Europace, 15, 1042, 10.1093/europace/eut018 Frommeyer, 2016, Drug-induced proarrhythmia: risk factors and electrophysiological mechanisms, Nat Rev Cardiol, 13, 36, 10.1038/nrcardio.2015.110 Mahida, 2013, Genetics of congenital and drug-induced long QT syndromes: current evidence and future research perspectives, J Interv Card Electrophysiol, 37, 9, 10.1007/s10840-013-9779-5 Tasolar, 2014, Effect of smoking on Tp-e interval, Tp-e/QT and Tp-e/QTc ratios as indices of ventricular arrhythmogenesis, Heart Lung Circ, 23, 827, 10.1016/j.hlc.2014.03.016 Ilgenli, 2015, The effects of cigarette smoking on the Tp-e interval, Tp-e/QT ratio and Tp-e/QTc ratio, Adv Clin Exp Med, 24, 973, 10.17219/acem/28114 Claudio Bde, 2014, Impact of psychotropic drugs on QT interval dispersion in adult patients, Arq Bras Cardiol, 102, 465 Howland, 2015, Psychiatric medications and sudden cardiac death: putting the risk in perspective, J Psychosoc Nurs Ment Health Serv, 53, 23 van Noord, 2011, Non-cardiovascular drugs that inhibit hERG-encoded potassium channels and risk of sudden cardiac death, Heart, 97, 215, 10.1136/hrt.2009.188367 Carlquist, 2015, A possible mechanistic link between the CYP2C19 genotype, the methadone metabolite ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidene (EDDP), and methadone-induced corrected QT interval prolongation in a pilot study, Mol Diagn Ther, 19, 131, 10.1007/s40291-015-0137-4 Perrin-Terrin, 2011, QT interval prolongation: prevalence, risk factors and pharmacovigilance data among methadone-treated patients in France, Fundam Clin Pharmacol, 25, 503, 10.1111/j.1472-8206.2010.00871.x Cheng, 2015, The role of macrolide antibiotics in increasing cardiovascular risk, J Am Coll Cardiol, 66, 2173, 10.1016/j.jacc.2015.09.029 Lertxundi, 2013, Domperidone in Parkinson's disease: a perilous arrhythmogenic or the gold standard?, Curr Drug Saf, 8, 63, 10.2174/1574886311308010009 Timour, 2012, Sudden death of cardiac origin and psychotropic drugs, Front Pharmacol, 3, 76, 10.3389/fphar.2012.00076 Chang, 2013, Nitric oxide synthase 1 adaptor protein, an emerging new genetic marker for QT prolongation and sudden cardiac death, Acta Cardiol Sin, 29, 217 Beitland, 2014, Drug-induced long QT syndrome and fatal arrhythmias in the intensive care unit, Acta Anaesthesiol Scand, 58, 266, 10.1111/aas.12257 Rabkin, 2015, Impact of age and sex on QT prolongation in patients receiving psychotropics, Can J Psychiatry, 60, 206, 10.1177/070674371506000502 Kozik, 2012, Acquired long QT syndrome: frequency, onset, and risk factors in intensive care patients, Crit Care Nurse, 32, 32, 10.4037/ccn2012900 Nakatani, 2014, A case of sudden cardiac death due to pilsicainide-induced torsades de pointes, Korean Circ J, 44, 122, 10.4070/kcj.2014.44.2.122 Karwatowska-Prokopczuk, 2013, The risk of sudden cardiac death in patients with non-ST elevation acute coronary syndrome and prolonged QTc interval: effect of ranolazine, Europace, 15, 429, 10.1093/europace/eus400 Miura, 2015, Risk factors for QT prolongation associated with acute psychotropic drug overdose, Am J Emerg Med, 33, 142, 10.1016/j.ajem.2014.09.048 Lusetti, 2015, Cardiac toxicity in selective serotonin reuptake inhibitor users, Am J Forensic Med Pathol, 36, 293, 10.1097/PAF.0000000000000205 Beach, 2014, Meta-analysis of selective serotonin reuptake inhibitor-associated QTc prolongation, J Clin Psychiatry, 75, e441, 10.4088/JCP.13r08672 Girardin, 2013, Drug-induced long QT in adult psychiatric inpatients: the 5-year cross-sectional ECG Screening Outcome in Psychiatry study, Am J Psychiatry, 170, 1468, 10.1176/appi.ajp.2013.12060860 Vieweg, 2012, Citalopram, QTc interval prolongation, and torsade de pointes. How should we apply the recent FDA ruling?, Am J Med, 125, 859, 10.1016/j.amjmed.2011.12.002 Jasiak, 2014, Risk of QT/QTc prolongation among newer non-SSRI antidepressants, Ann Pharmacother, 48, 1620, 10.1177/1060028014550645 Leonard, 2011, Antidepressants and the risk of sudden cardiac death and ventricular arrhythmia, Pharmacoepidemiol Drug Saf, 20, 903, 10.1002/pds.2181 Wu, 2015, Antipsychotic drugs and the risk of ventricular arrhythmia and/or sudden cardiac death: a nation-wide case-crossover study, J Am Heart Assoc, 4, 10.1161/JAHA.114.001568 Raschi, 2013, Torsadogenic risk of antipsychotics: combining adverse event reports with drug utilization data across Europe, PLoS ONE, 8, e81208, 10.1371/journal.pone.0081208 Poluzzi, 2013, Antipsychotics and torsadogenic risk: signals emerging from the US FDA Adverse Event Reporting System database, Drug Saf, 36, 467, 10.1007/s40264-013-0032-z Fanoe, 2014, Risk of arrhythmia induced by psychotropic medications: a proposal for clinical management, Eur Heart J, 35, 1306, 10.1093/eurheartj/ehu100 Raschi, 2016, The contribution of national spontaneous reporting systems to detect signals of torsadogenicity: issues emerging from the ARITMO project, Drug Saf, 39, 59, 10.1007/s40264-015-0353-1 Leonard, 2013, Antipsychotics and the risks of sudden cardiac death and all-cause death: cohort studies in Medicaid and dually-eligible Medicaid-Medicare beneficiaries of five states, J Clin Exp Cardiolog, 10, 1 Grande, 2011, QTc prolongation: is clozapine safe? Study of 82 cases before and after clozapine treatment, Hum Psychopharmacol, 26, 397 Strom, 2011, Comparative mortality associated with ziprasidone and olanzapine in real-world use among 18,154 patients with schizophrenia: The Ziprasidone Observational Study of Cardiac Outcomes (ZODIAC), Am J Psychiatry, 168, 193, 10.1176/appi.ajp.2010.08040484 Geier, 2011, Methodological challenges in the coding and adjudication of sudden deaths in a large simple trial with observational follow-up: the ziprasidone observational study of cardiac outcomes (ZODIAC), Pharmacoepidemiol Drug Saf, 20, 1192, 10.1002/pds.2185 Citrome, 2011, Drug safety evaluation of ziprasidone, Expert Opin Drug Saf, 10, 437, 10.1517/14740338.2011.560114 Polcwiartek, 2015, The cardiac safety of aripiprazole treatment in patients at high risk for torsade: a systematic review with a meta-analytic approach, Psychopharmacology (Berl), 232, 3297, 10.1007/s00213-015-4024-9 Polcwiartek, 2016, Cardiovascular safety of antipsychotics: a clinical overview, Expert Opin Drug Saf, 15, 679, 10.1517/14740338.2016.1161021 Hasnain, 2014, Quetiapine, QTc interval prolongation, and torsade de pointes: a review of case reports, Ther Adv Psychopharmacol, 4, 130, 10.1177/2045125313510194 Watanabe, 2012, Increased risk of antipsychotic-related QT prolongation during nighttime: a 24-hour holter electrocardiogram recording study, J Clin Psychopharmacol, 32, 18, 10.1097/JCP.0b013e31823f6f21 Suzuki, 2012, QT prolongation of the antipsychotic risperidone is predominantly related to its 9-hydroxy metabolite paliperidone, Hum Psychopharmacol, 27, 39, 10.1002/hup.1258 Oteri, 2016, Prescribing pattern of antipsychotic drugs during the years 1996–2010: a population-based database study in Europe with a focus on torsadogenic drugs, Br J Clin Pharmacol, 82, 487, 10.1111/bcp.12955 Johnsen, 2013, QTc prolongation in patients acutely admitted to hospital for psychosis and treated with second generation antipsychotics, Schizophr Res Treatment, 2013, 375020, 10.1155/2013/375020 Correll, 2011, Antipsychotic drug administration does not correlate with prolonged rate-corrected QT interval in children and adolescents: results from a nested case-control study, J Child Adolesc Psychopharmacol, 21, 365, 10.1089/cap.2011.0024 Ray, 2012, Azithromycin and the risk of cardiovascular death, N Engl J Med, 366, 1881, 10.1056/NEJMoa1003833 Rao, 2014, Azithromycin and levofloxacin use and increased risk of cardiac arrhythmia and death, Ann Fam Med, 12, 121, 10.1370/afm.1601 An, 2013, Sudden cardiac arrest during anesthesia in a 30-month-old boy with syndactyly: a case of genetically proven Timothy syndrome, J Korean Med Sci, 28, 788, 10.3346/jkms.2013.28.5.788 Leelakanok, 2016, Domperidone and risk of ventricular arrhythmia and cardiac death: a systematic review and meta-analysis, Clin Drug Investig, 36, 97, 10.1007/s40261-015-0360-0 Arana, 2015, Risk of out-of-hospital sudden cardiac death in users of domperidonem proton pump inhibitors, or metoclopramide: a population-based nested case-control study, Drug Saf, 38, 1187, 10.1007/s40264-015-0338-0 Moffett, 2016, Intravenous ondansetron and the QT interval in adult emergency department patients: an observational study, Acad Emerg Med, 23, 102, 10.1111/acem.12836 Poluzzi, 2015, Pro-arrhythmic potential of oral antihistamines (H1): combining adverse event reports with drug utilization data across Europe, PLOS ONE, 10, e0119551, 10.1371/journal.pone.0119551 Kim, 2014, Chemotherapy and QT prolongation: overview with clinical perspective, Curr Treat Options Cardiovasc Med, 16, 303, 10.1007/s11936-014-0303-8 Bronte, 2015, What links BRAF to the heart function? New insights from the cardiotoxicity of BRAF inhibitors in cancer treatment, Oncotarget, 6, 35589, 10.18632/oncotarget.5853 Martinez-Raga, 2013, Risk of serious cardiovascular problems with medications for attention-deficit hyperactivity disorder, CNS Drugs, 27, 15, 10.1007/s40263-012-0019-9 Westover, 2012, Do prescription stimulants increase the risk of adverse cardiovascular events?: A systematic review, BMC Cardiovasc Disord, 12, 41, 10.1186/1471-2261-12-41 Schelleman, 2012, Methylphenidate and risk of serious cardiovascular events in adults, Am J Psychiatry, 169, 178, 10.1176/appi.ajp.2011.11010125 Zhang, 2011, Coffee, alcohol, smoking, physical activity and QT interval duration: results from the Third National Health and Nutrition Examination Survey, PLoS ONE, 6, e17584, 10.1371/journal.pone.0017584 Torbey, 2011, Ginseng: a potential cause of long QT, J Electrocardiol, 44, 357, 10.1016/j.jelectrocard.2010.08.007 Ozturk, 2013, Polymorphic ventricular tachycardia (Torsades de pointes) due to licorice root tea, Turk Kardiyol Dern Ars, 41, 241, 10.5543/tkda.2013.72547 Shah, 2010, Drug-induced QT interval shortening: potential harbinger of proarrhythmia and regulatory perspectives, Br J Pharmacol, 159, 58, 10.1111/j.1476-5381.2009.00191.x Schimpf, 2012, Drug-induced QT-interval shortening following antiepileptic treatment with oral rufinamide, Heart Rhythm, 9, 776, 10.1016/j.hrthm.2012.01.006 Letsas, 2013, Drug-induced Brugada syndrome by noncardiac agents, Pacing Clin Electrophysiol, 36, 1570, 10.1111/pace.12234 Almroth, 2011, The safety of flecainide treatment of atrial fibrillation: long-term incidence of sudden cardiac death and proarrhythmic events, J Intern Med, 270, 281, 10.1111/j.1365-2796.2011.02395.x Bajaj, 2014, Brugada electrocardiogram pattern “unmasked” by amiodarone infusion, Am J Ther, 21, 540, 10.1097/01.mjt.0000433948.16654.91 Bardai, 2015, Sudden cardiac death is associated both with epilepsy and with use of antiepileptic medications, Heart, 101, 17, 10.1136/heartjnl-2014-305664 Ishizue, 2016, Polytherapy with sodium channel-blocking antiepileptic drugs is associated with arrhythmogenic ST-T abnormality in patients with epilepsy, Seizure, 40, 81, 10.1016/j.seizure.2016.06.004 Ondrejka, 2015, Type 1 Brugada pattern associated with nicotine toxicity, J Emerg Med, 49, e183, 10.1016/j.jemermed.2015.08.008